PHGE
BiomX Inc. · AMEX
- Sector Health Technology
- Industry Biotechnology
- Website biomx.com
- Employees(FY) 54
- ISIN US09090D1037
Performance
-5.89%
1W
+20.87%
1M
+47.3%
3M
-17.57%
6M
+21.0%
YTD
+21.7%
1Y
Profile
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC). It is developing BX004, a phage therapy for CF patients with chronic Pseudomonas aeruginosa respiratory infections that is in Phase 1b/2a clinical trials. The company's pipeline products also include BX005, a topical phage cocktail, which is in Phase 1/2 clinical study that targets Staphylococcus aureus (S. aureus), a bacteria associated with the manifestation of the disease. In addition, the company engages in the provision of colorectal cancer program that utilizes engineered phage with various payloads, which are administered intravenously to target Fusobacterium nucleatum bacteria residing within the tumor microenvironment. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
Technical Analysis of PHGE 2024-05-10
Overview:
In analyzing the technical indicators for PHGE over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions to guide your invest...
Recent News & Updates
- 2023-02-21 17:35
BiomX Announces $7.5 Million Private Placement(Yahoo Finance)
- 2023-02-21 17:30
- 2022-11-28 20:10
- 2022-11-08 17:30
- 2022-11-01 21:00
- 2022-09-10 19:22
- 2022-08-09 18:30
- 2022-08-06 15:17
- 2022-08-03 23:20
- 2022-07-05 13:45
- 2022-06-27 18:30
- 2022-06-26 18:30
- 2022-05-23 13:52
BiomX Announces Corporate Restructuring(Yahoo Finance)
- 2022-05-19 20:00
BiomX Announces Publication in the Journal, Bioinformatics(Yahoo Finance)
- 2022-05-10 18:30
- 2022-05-05 19:00
- 2022-05-04 20:00
- 2022-03-29 18:30
- 2022-03-22 20:00
- 2022-02-23 19:00
BiomX Presenting at Three Upcoming Investor Conferences(Yahoo Finance)
- 2022-01-03 18:00
- 2021-11-16 19:00
BiomX Presenting at Two Upcoming Conferences in November(Yahoo Finance)
- 2021-11-14 17:00
- 2021-11-08 19:00
- 2021-10-24 22:00
- 2021-10-17 19:00
BiomX Reports Topline Results of Phase 2 Cosmetic Acne Study(Yahoo Finance)
- 2021-10-12 19:00
- 2021-09-02 04:05
BiomX to Present at Upcoming September Investor Conferences(Yahoo Finance)
- 2021-08-15 18:30
- 2021-08-11 20:00